|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This site is dedicated to Cindi McCain & Lou Grubb: Friends & Stroke Survivors....(ALLOW 1 MINUTE TO LOAD)....We search 100's of internet sites for daily news: New York Times, Washington Post, LA Times, Chicago Tribune, Harvard, Yale, UCLA, CNN, FOX, CBS, NBC, ABC, BBC, Journal of American Medical Assoc., New England Journal of Medicine, Mayo Clinic, Johns Hopkins Medicine, Cleveland Clinic, Memorial Sloan- Kettering, Reuters & 100's more...(WE DO NOT ACCEPT ADVERTISING) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
TuesdayVIDEO: New Drug-Eluting Stent Stumbles on Primary Endpoint Yet Maintains Momentum
In a large U.S. study of an investigational third-generation drug-eluting coronary-artery stent, called Endeavor, the device failed to meet its primary endpoint, an angiographic surrogate marker. But the investigators were not all frowns. The clinical results were as good as those seen in patients treated with Cypher, the Rapamycin (sirolimus)-eluting stent that changed the world of interventional cardiology when it was approved in 2003, researchers said today....Click to watch video... - CME Teaching Brief - MedPage Today
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||